Related Experiment Video

Updated: Aug 22, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Importance of ets1 proto-oncogene for breast cancer progression

J Dittmer1, M Vetter, S G Blumenthal

  • 1Universität Halle-Wittenberg, Universitätsklinik und Poliklinik für Gynäkologie, Halle (Saale), Germany. juergen.dittmer@medizin.uni-halle.de

Zentralblatt Fur Gynakologie
|September 25, 2004
PubMed

Insights

Ets1 transcription factor regulates specific matrix-degrading proteases in invasive breast cancer cells. Protein kinase C may control Ets1 activity, offering potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Ets proteins are transcription factors characterized by a unique DNA-binding Ets domain.
  • Certain Ets family members, including Ets1, are linked to tumorigenesis.
  • Ets1 is highly expressed in invasive tumors and can activate genes for extracellular matrix (ECM)-degrading proteases.

Purpose of the Study:

  • To identify Ets1-regulated genes in MDA-MB-231 breast cancer cells.
  • To investigate the role of Ets1 in regulating ECM-degrading proteases.
  • To explore the regulation of Ets1 activity in invasive breast cancer.

Main Methods:

  • RNA-interference was used to suppress endogenous Ets1 expression.
  • DNA chip analysis (microarray) was employed to identify Ets1-responsive genes.
  • The effect of protein kinase C (PKC) inhibitors on Ets1 expression was assessed.

Main Results:

  • Suppression of Ets1 led to reduced RNA levels for matrix metalloproteinases MMP1 and MMP9, but not MMP3 or uPA.
  • These findings indicate that Ets1 regulates a specific subset of ECM-degrading proteases.
  • Protein kinase C inhibition reduced Ets1 expression, while PKC activation enhanced Ets1-dependent transcription.

Conclusions:

  • Ets1 plays a role in regulating specific ECM-degrading proteases in breast cancer cells.
  • Protein kinase C emerges as a potential regulator of Ets1 activity in invasive breast cancer.
  • Targeting the Ets1 pathway or its regulators like PKC could be a strategy for breast cancer treatment.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...